Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antigen Processing Pathways01:31

Antigen Processing Pathways

2.9K
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
2.9K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.7K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.7K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

13.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
13.7K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.4K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

7.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

8.4K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
8.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Rapid Binder Discovery Workflow for Engineering Mini-Protein Degraders.

Journal of the American Chemical Society·2026
Same author

Integrative Computational Approaches to Prostate Cancer with Conditional Reprogramming and AI-Driven Precision Medicine.

Cells·2026
Same author

Rethinking ovarian cancer III: the past decade and future directions.

Nature reviews. Cancer·2026
Same author

Tracking the Metabolites of Health and Disease Using Artificial Intelligence.

Diseases (Basel, Switzerland)·2026
Same author

Adoptive cell therapy for ovarian cancer.

Clinical advances in hematology & oncology : H&O·2026
Same author

Probing Cellular Activity Via Charge-Sensitive Quantum Nanoprobes.

Advanced materials (Deerfield Beach, Fla.)·2026

Related Experiment Video

Updated: Apr 30, 2026

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

10.0K

Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by

Junko Matsuzaki1, Takemasa Tsuji, Immanuel Luescher

  • 1Authors' Affiliations: Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Switzerland.

Cancer Immunology Research
|April 26, 2014
PubMed
Summary

Cancer cells present intracellular tumor antigens on MHC class II molecules through novel pathways, enabling direct recognition by CD4(+) T cells. This finding offers new strategies for enhancing antitumor immunity in challenging tumor microenvironments.

More Related Videos

Visualizing Antigen Specific CD4+ T Cells using MHC Class II Tetramers
15:42

Visualizing Antigen Specific CD4+ T Cells using MHC Class II Tetramers

Published on: March 6, 2009

21.1K
In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers
13:10

In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers

Published on: August 1, 2014

10.8K

Related Experiment Videos

Last Updated: Apr 30, 2026

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

10.0K
Visualizing Antigen Specific CD4+ T Cells using MHC Class II Tetramers
15:42

Visualizing Antigen Specific CD4+ T Cells using MHC Class II Tetramers

Published on: March 6, 2009

21.1K
In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers
13:10

In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers

Published on: August 1, 2014

10.8K

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Mechanisms of Antigen Presentation

Background:

  • CD4(+) T cells are crucial for antitumor immunity, but their direct recognition of cancer cells via MHC class II (MHC-II) presentation of intracellular antigens is not well understood.
  • Understanding these mechanisms is key to developing effective cancer immunotherapies.

Purpose of the Study:

  • To elucidate the mechanisms by which cancer cells present intracellular tumor antigens on MHC-II molecules.
  • To identify distinct CD4(+) T cell subsets involved in recognizing intracellular tumor antigens.
  • To explore novel antigen processing pathways involved in MHC-II presentation.

Main Methods:

  • NY-ESO-1 peptide vaccination in ovarian cancer patients.
  • Analysis of CD4(+) T cell subsets recognizing exogenous and intracellular tumor antigens.
  • Investigation of antigen processing pathways, including MHC class I pathways, endosomal/lysosomal proteases, and proteasomal degradation.
  • Pharmacological inhibition using primaquine to study antigen presentation.

Main Results:

  • Two distinct CD4(+) T cell subsets were identified after vaccination, with one subset specifically recognizing intracellular NY-ESO-1 expression on cancer cells.
  • Tumor-recognizing CD4(+) T cells showed higher affinity for shorter peptides (8-9 mer).
  • MHC-II presentation of intracellular NY-ESO-1 involved both classical MHC-II and non-classical MHC class I antigen processing pathways (proteasomal degradation, TAP).
  • Primaquine inhibited antigen presentation, suggesting a role for endosomal recycling.

Conclusions:

  • Cancer cells utilize multiple, non-classical antigen processing pathways to present intracellular tumor antigens on MHC-II.
  • Direct recognition of tumor antigens by CD4(+) T cells is feasible and can be mediated by these novel pathways.
  • Targeting these pathways and harnessing direct tumor-recognizing CD4(+) T cells holds promise for improving antitumor immune responses, especially in immunosuppressive tumor microenvironments.